Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000899243-16-017929)

Filing Details

Accession Number:: 0000899243-16-017929
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-04-11 17:47:38
Reporting Period:: 2016-04-07

Filing Date:: 2016-04-11
Accepted Time:: 2016-04-11 17:47:38
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1609809	Seres Therapeutics Inc.	MCRB	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1233684	N David Cook	C/O Seres Therapeutics, Inc. 215 First Street Cambridge MA 02142	Chief Scientific Officer & Evp	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2016-04-07	8,000	$31.00	160,673	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 2, 2016.